Home›Stock Screener›Bliss GVS Pharma›Quarterly Results

Bliss GVS Pharma Quarterly Results

Latest Quarter Net Profit
₹37 Cr
QMar 2026
Quarterly Results

Bliss GVS Pharma quarterly results. In Mar 2026, Bliss GVS Pharma (BLISSGVS) reported revenue ₹268 Cr and net profit ₹37 Cr — revenue +27.6% YoY. Review BLISSGVS price earnings ratio to evaluate earnings-based valuation against sector peers.

BLISSGVS Quarterly Results — Revenue, Profit & EPS Highlights

Bliss GVS Pharma latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit Bliss GVS Pharma share price screener.

  • Revenue of ₹268 Cr in Mar 2026 (-9.2% vs Jun 2026, +27.6% vs Mar 2025)
  • Net Profit of ₹37 Cr in Mar 2026 (-27.5% vs Jun 2026, +117.6% vs Mar 2025)
  • EBITDA of ₹56 Cr in Mar 2026 (-34.9% vs Jun 2026)
  • Operating Margin of 17.0% in Mar 2026 (-10.0pp vs Jun 2026)
  • Earnings Per Share of ₹3.37 in Mar 2026 (-28.8% vs Jun 2026)

Bliss GVS Pharma Quarterly Results — Revenue, EBITDA, Net Profit & EPS

BLISSGVS quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 268 295 253 210 243 -9.2% 27.6%
Net Profit (₹ Cr) 37 51 29 17 44 - -
EBITDA (₹ Cr) 56 86 52 33 77 - -
EPS (₹) 3.37 4.73 2.58 1.47 4.08 - -
Operating Margin (%) 17.0% 27.0% 18.0% 11.0% 20.0% - -

BLISSGVS Share Price Trend — 1-Year Movement Across Quarterly Results

Bliss GVS Pharma 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Check BLISSGVS market cap trends to track the company's total market size over time.

Profitability Ratios

Profit Margin 13.8%
EBITDA Margin 20.9%
Operating Margin 17.0%
ROE (Annual) 12.0%

Balance Sheet Highlights

Total Assets ₹1,492 Cr
Total Equity ₹1,232 Cr
Current Assets ₹946 Cr
Current Liabilities ₹25 Cr

Cash Flow Analysis

Operating Cash Flow ₹139 Cr
Investing Cash Flow ₹-38 Cr
Financing Cash Flow ₹-89 Cr
Net Cash Flow ₹11 Cr

Current Market Data

Current Price ₹523.55
Exchange NSE
Last Updated Jul 01, 2026

Revenue Trend (₹ Cr)

Mar 2025 210
Sept 2025 253
Jun 2026 295
Mar 2026 268

Net Profit Trend (₹ Cr)

Mar 2025 17
Sept 2025 29
Jun 2026 51
Mar 2026 37

Operating Margin Trend (%)

Mar 2025 11.0%
Sept 2025 18.0%
Jun 2026 27.0%
Mar 2026 17.0%

BLISSGVS vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Bliss GVS Pharma latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹432,120.23 Cr 1779.7 15,018 2,710 -5.6% - 18.0% 157.5
Divis Laboratories
Mar 2026 		₹253,522.49 Cr 9196.0 2,986 751 -5.0% - 25.2% 324.8
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4772.0 4,111 364 +27.7% +42.2% 8.9% 414.6
Zydus Life Science
Mar 2026 		₹113,615.69 Cr 1139.0 7,569 1,341 -4.3% - 17.7% 90.0
Cipla
Mar 2026 		₹108,576.18 Cr 1335.5 6,612 543 -9.3% - 8.2% 194.4
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores